UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.529

Sortiert nach

Co‐administration of rivaroxaban with drugs that share its elimination pathways: pharmacokinetic effects in healthy subjects

British journal of clinical pharmacology, 2013-09, Vol.76 (3), p.455-466

2013

Volltextzugriff (PDF)

Contribution of midazolam and its 1-hydroxy metabolite to preoperative sedation in children: a pharmacokinetic-pharmacodynamic analysis

British journal of anaesthesia : BJA, 2002-09, Vol.89 (3), p.428-437

2002

Volltextzugriff (PDF)

Scaling clearance in paediatric pharmacokinetics: All models are wrong, which are useful?

British journal of clinical pharmacology, 2017-04, Vol.83 (4), p.777-790

2017

Volltextzugriff (PDF)

Geneva Cocktail for Cytochrome P450 and P-Glycoprotein Activity Assessment Using Dried Blood Spots

Clinical pharmacology and therapeutics, 2014-09, Vol.96 (3), p.349-359

2014

Volltextzugriff (PDF)

Nonalcoholic Fatty Liver Disease and Diabetes Are Associated with Decreased CYP3A4 Protein Expression and Activity in Human Liver

Molecular pharmaceutics, 2018-07, Vol.15 (7), p.2621-2632

2018

Volltextzugriff (PDF)

Development of a Novel Maternal-Fetal Physiologically Based Pharmacokinetic Model II: Verification of the model for passive placental permeability drugs

Drug metabolism and disposition, 2017-08, Vol.45 (8), p.939-946

2017

Volltextzugriff (PDF)

Time Course of the Interaction Between Oral Short-Term Ritonavir Therapy with Three Factor Xa Inhibitors and the Activity of CYP2D6, CYP2C19, and CYP3A4 in Healthy Volunteers

Clinical pharmacokinetics, 2024-04, Vol.63 (4), p.469-481

2024

Volltextzugriff (PDF)

Assessing Transporter‐Mediated Natural Product‐Drug Interactions Via In vitro‐In Vivo Extrapolation: Clinical Evaluation With a Probe Cocktail

Clinical pharmacology and therapeutics, 2021-05, Vol.109 (5), p.1342-1352

2021

Volltextzugriff (PDF)

Evaluation of potential herbal-drug interactions of a standardized propolis extract (EPP-AF®) using an in vivo cocktail approach

Journal of ethnopharmacology, 2019-12, Vol.245, p.112174, Article 112174

2019

Volltextzugriff (PDF)

Characterization of Pediatric Rectal Absorption, Drug Disposition, and Sedation Level for Midazolam Gel Using Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling

Molecular pharmaceutics, 2024-05, Vol.21 (5), p.2187-2197

2024

Volltextzugriff (PDF)

Generation of intestinal organoids derived from human pluripotent stem cells for drug testing

Scientific reports, 2020-04, Vol.10 (1), p.5989, Article 5989

2020

Volltextzugriff (PDF)

Pharmacokinetics and Pharmacodynamics of GS-9350: A Novel Pharmacokinetic Enhancer Without Anti-HIV Activity

Clinical pharmacology and therapeutics, 2010-03, Vol.87 (3), p.322-329

2010

Volltextzugriff (PDF)

Phenobarbital, Midazolam Pharmacokinetics, Effectiveness, and Drug-Drug Interaction in Asphyxiated Neonates Undergoing Therapeutic Hypothermia

Neonatology (Basel, Switzerland), 2019-08, Vol.116 (2), p.154-162

2019

Volltextzugriff (PDF)

Evaluation of Cytochrome P450‐Mediated Cannabinoid‐Drug Interactions in Healthy Adult Participants

Clinical pharmacology and therapeutics, 2023-09, Vol.114 (3), p.693-703

2023

Volltextzugriff (PDF)

Midostaurin drug interaction profile: a comprehensive assessment of CYP3A, CYP2B6, and CYP2C8 drug substrates, and oral contraceptives in healthy participants

Cancer chemotherapy and pharmacology, 2024-05, Vol.93 (5), p.439-453

2024

Volltextzugriff (PDF)

Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations

The Journal of pharmacology and experimental therapeutics, 2021-01, Vol.376 (1), p.64

2021

Volltextzugriff (PDF)

Simultaneous Physiologically Based Pharmacokinetic (PBPK) Modeling of Parent and Active Metabolites to Investigate Complex CYP3A4 Drug-Drug Interaction Potential: A Case Example of Midostaurin

Drug metabolism and disposition, 2018-02, Vol.46 (2), p.109-121

2018

Volltextzugriff (PDF)

Effects of Pregnancy on CYP3A and P-glycoprotein Activities as Measured by Disposition of Midazolam and Digoxin: A University of Washington Specialized Center of Research Study

Clinical pharmacology and therapeutics, 2008-08, Vol.84 (2), p.248-253

2008

Volltextzugriff (PDF)

Physiologically Based Pharmacokinetic Modelling to Investigate the Impact of the Cytokine Storm on CYP3A Drug Pharmacokinetics in COVID‐19 Patients

Clinical pharmacology and therapeutics, 2022-03, Vol.111 (3), p.579-584

2022

Volltextzugriff (PDF)

Physiologically based pharmacokinetic modeling of ritonavir-oxycodone drug interactions and its implication for dosing strategy

European journal of pharmaceutical sciences, 2024-03, Vol.194, p.106697-106697, Article 106697

2024

Volltextzugriff (PDF)

Grading the level of evidence of neonatal pharmacotherapy: midazolam and phenobarbital as examples

Pediatric research, 2024-01, Vol.95 (1), p.75-83

2024

Volltextzugriff (PDF)

Exploring the Use of Serum‐Derived Small Extracellular Vesicles as Liquid Biopsy to Study the Induction of Hepatic Cytochromes P450 and Organic Anion Transporting Polypeptides

Clinical pharmacology and therapeutics, 2021-07, Vol.110 (1), p.248-258

2021

Volltextzugriff (PDF)

Pharmacokinetic and Pharmacodynamic Alterations in the Roux-en-Y Gastric Bypass Recipients

Annals of surgery, 2013-08, Vol.258 (2), p.262-269

2013

Volltextzugriff (PDF)

Complex Cytochrome P450 Kinetics Due to Multisubstrate Binding and Sequential Metabolism. Part 2. Modeling of Experimental Data

Drug metabolism and disposition, 2021-12, Vol.49 (12), p.1100-1108

2021

Volltextzugriff (PDF)

A Placebo- and Midazolam-Controlled Phase I Single Ascending-Dose Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of Remimazolam (CNS 7056): Part II. Population Pharmacokinetic and Pharmacodynamic Modeling and Simulation

Anesthesia and analgesia, 2012-08, Vol.115 (2), p.284-296

2012

Volltextzugriff (PDF)

1 – 25 von 1.529

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.441)
Mit Volltextzugriff
(1.126)

Publikationsform

Artikel
(1.523)
Buchkapitel
(6)

Sprache

10 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.335)
Life Sciences & Biomedicine
(1.305)
Humans
(1.134)
Midazolam - Pharmacokinetics
(1.059)
Pharmacology & Pharmacy
(946)
Male
(870)
Midazolam
(698)
Female
(589)
Adult
(586)
Biological And Medical Sciences
(557)
Pharmacokinetics
(555)
Medical Sciences
(545)
Pharmacology. Drug Treatments
(496)
Midazolam - Administration & Dosage
(435)
Drug Interactions
(431)
Middle Aged
(364)
Animals
(352)
Midazolam - Blood
(352)
Cytochrome P-450 Cyp3a - Metabolism
(306)
Area Under Curve
(261)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Co‐administration of rivaroxaban with drugs that share its elimination pathways: pharmacokinetic effects in healthy subjects

Contribution of midazolam and its 1-hydroxy metabolite to preoperative sedation in children: a pharmacokinetic-pharmacodynamic analysis

Scaling clearance in paediatric pharmacokinetics: All models are wrong, which are useful?

Geneva Cocktail for Cytochrome P450 and P-Glycoprotein Activity Assessment Using Dried Blood Spots

Nonalcoholic Fatty Liver Disease and Diabetes Are Associated with Decreased CYP3A4 Protein Expression and Activity in Human Liver

Development of a Novel Maternal-Fetal Physiologically Based Pharmacokinetic Model II: Verification of the model for passive placental permeability drugs

Time Course of the Interaction Between Oral Short-Term Ritonavir Therapy with Three Factor Xa Inhibitors and the Activity of CYP2D6, CYP2C19, and CYP3A4 in Healthy Volunteers

Assessing Transporter‐Mediated Natural Product‐Drug Interactions Via In vitro‐In Vivo Extrapolation: Clinical Evaluation With a Probe Cocktail

Evaluation of potential herbal-drug interactions of a standardized propolis extract (EPP-AF®) using an in vivo cocktail approach

Characterization of Pediatric Rectal Absorption, Drug Disposition, and Sedation Level for Midazolam Gel Using Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling

Generation of intestinal organoids derived from human pluripotent stem cells for drug testing

Pharmacokinetics and Pharmacodynamics of GS-9350: A Novel Pharmacokinetic Enhancer Without Anti-HIV Activity

Phenobarbital, Midazolam Pharmacokinetics, Effectiveness, and Drug-Drug Interaction in Asphyxiated Neonates Undergoing Therapeutic Hypothermia

Evaluation of Cytochrome P450‐Mediated Cannabinoid‐Drug Interactions in Healthy Adult Participants

Midostaurin drug interaction profile: a comprehensive assessment of CYP3A, CYP2B6, and CYP2C8 drug substrates, and oral contraceptives in healthy participants

Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations

Simultaneous Physiologically Based Pharmacokinetic (PBPK) Modeling of Parent and Active Metabolites to Investigate Complex CYP3A4 Drug-Drug Interaction Potential: A Case Example of Midostaurin

Effects of Pregnancy on CYP3A and P-glycoprotein Activities as Measured by Disposition of Midazolam and Digoxin: A University of Washington Specialized Center of Research Study

Physiologically Based Pharmacokinetic Modelling to Investigate the Impact of the Cytokine Storm on CYP3A Drug Pharmacokinetics in COVID‐19 Patients

Physiologically based pharmacokinetic modeling of ritonavir-oxycodone drug interactions and its implication for dosing strategy

Grading the level of evidence of neonatal pharmacotherapy: midazolam and phenobarbital as examples

Exploring the Use of Serum‐Derived Small Extracellular Vesicles as Liquid Biopsy to Study the Induction of Hepatic Cytochromes P450 and Organic Anion Transporting Polypeptides

Pharmacokinetic and Pharmacodynamic Alterations in the Roux-en-Y Gastric Bypass Recipients

Complex Cytochrome P450 Kinetics Due to Multisubstrate Binding and Sequential Metabolism. Part 2. Modeling of Experimental Data

A Placebo- and Midazolam-Controlled Phase I Single Ascending-Dose Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of Remimazolam (CNS 7056): Part II. Population Pharmacokinetic and Pharmacodynamic Modeling and Simulation

Suchergebnisse filtern